- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 60 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.4: 1 residues within 4Å:- Chain A: N.57
Ligand excluded by PLIPNAG.5: 3 residues within 4Å:- Chain A: N.118, T.120, V.123
Ligand excluded by PLIPNAG.6: 2 residues within 4Å:- Chain A: N.159, N.160
Ligand excluded by PLIPNAG.7: 11 residues within 4Å:- Chain A: T.104, N.229, T.231
- Chain C: R.452, S.454, K.455, K.457
- Chain E: R.452, S.454, K.455, K.457
Ligand excluded by PLIPNAG.8: 4 residues within 4Å:- Chain A: E.276, N.277
- Chain C: K.553
- Chain E: K.553
Ligand excluded by PLIPNAG.9: 2 residues within 4Å:- Chain A: N.326, Q.575
Ligand excluded by PLIPNAG.10: 3 residues within 4Å:- Chain A: H.334, N.338, F.366
Ligand excluded by PLIPNAG.11: 5 residues within 4Å:- Chain A: N.611, T.613, Q.639
- Chain B: I.829
- Chain D: I.829
Ligand excluded by PLIPNAG.12: 1 residues within 4Å:- Chain A: N.652
Ligand excluded by PLIPNAG.13: 3 residues within 4Å:- Chain A: Y.702, S.703, N.704
Ligand excluded by PLIPNAG.14: 4 residues within 4Å:- Chain A: E.1067, N.1069
- Chain B: Q.890
- Chain D: Q.890
Ligand excluded by PLIPNAG.15: 1 residues within 4Å:- Chain A: N.1129
Ligand excluded by PLIPNAG.19: 3 residues within 4Å:- Chain B: N.57
- Chain D: N.57
- Ligands: NAG.49
Ligand excluded by PLIPNAG.20: 7 residues within 4Å:- Chain B: N.118, T.120, V.123
- Chain D: N.118, T.120, V.123
- Ligands: NAG.50
Ligand excluded by PLIPNAG.21: 5 residues within 4Å:- Chain B: N.159, N.160
- Chain D: N.159, N.160
- Ligands: NAG.51
Ligand excluded by PLIPNAG.22: 11 residues within 4Å:- Chain A: R.452, S.454, K.455, K.457
- Chain B: T.104, N.229, T.231
- Chain D: T.104, N.229, T.231
- Ligands: NAG.52
Ligand excluded by PLIPNAG.23: 6 residues within 4Å:- Chain A: K.553
- Chain B: E.276, N.277
- Chain D: E.276, N.277
- Ligands: NAG.53
Ligand excluded by PLIPNAG.24: 5 residues within 4Å:- Chain B: N.326, Q.575
- Chain D: N.326, Q.575
- Ligands: NAG.54
Ligand excluded by PLIPNAG.25: 7 residues within 4Å:- Chain B: H.334, N.338, F.366
- Chain D: H.334, N.338, F.366
- Ligands: NAG.55
Ligand excluded by PLIPNAG.26: 9 residues within 4Å:- Chain B: N.611, T.613, Q.639
- Chain C: I.829
- Chain D: N.611, T.613, Q.639
- Chain E: I.829
- Ligands: NAG.56
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain B: N.652
- Chain D: N.652
- Ligands: NAG.57
Ligand excluded by PLIPNAG.28: 7 residues within 4Å:- Chain B: Y.702, S.703, N.704
- Chain D: Y.702, S.703, N.704
- Ligands: NAG.58
Ligand excluded by PLIPNAG.29: 7 residues within 4Å:- Chain B: E.1067, N.1069
- Chain C: Q.890
- Chain D: E.1067, N.1069
- Chain E: Q.890
- Ligands: NAG.59
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain B: N.1129
- Chain D: N.1129
- Ligands: NAG.60
Ligand excluded by PLIPNAG.34: 3 residues within 4Å:- Chain C: N.57
- Chain E: N.57
- Ligands: NAG.64
Ligand excluded by PLIPNAG.35: 7 residues within 4Å:- Chain C: N.118, T.120, V.123
- Chain E: N.118, T.120, V.123
- Ligands: NAG.65
Ligand excluded by PLIPNAG.36: 5 residues within 4Å:- Chain C: N.159, N.160
- Chain E: N.159, N.160
- Ligands: NAG.66
Ligand excluded by PLIPNAG.37: 15 residues within 4Å:- Chain B: R.452, S.454, K.455, K.457
- Chain C: T.104, N.229, T.231
- Chain D: R.452, S.454, K.455, K.457
- Chain E: T.104, N.229, T.231
- Ligands: NAG.67
Ligand excluded by PLIPNAG.38: 7 residues within 4Å:- Chain B: K.553
- Chain C: E.276, N.277
- Chain D: K.553
- Chain E: E.276, N.277
- Ligands: NAG.68
Ligand excluded by PLIPNAG.39: 5 residues within 4Å:- Chain C: N.326, Q.575
- Chain E: N.326, Q.575
- Ligands: NAG.69
Ligand excluded by PLIPNAG.40: 7 residues within 4Å:- Chain C: H.334, N.338, F.366
- Chain E: H.334, N.338, F.366
- Ligands: NAG.70
Ligand excluded by PLIPNAG.41: 8 residues within 4Å:- Chain A: I.829
- Chain C: N.611, T.613, Q.639
- Chain E: N.611, T.613, Q.639
- Ligands: NAG.71
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain C: N.652
- Chain E: N.652
- Ligands: NAG.72
Ligand excluded by PLIPNAG.43: 7 residues within 4Å:- Chain C: Y.702, S.703, N.704
- Chain E: Y.702, S.703, N.704
- Ligands: NAG.73
Ligand excluded by PLIPNAG.44: 6 residues within 4Å:- Chain A: Q.890
- Chain C: E.1067, N.1069
- Chain E: E.1067, N.1069
- Ligands: NAG.74
Ligand excluded by PLIPNAG.45: 3 residues within 4Å:- Chain C: N.1129
- Chain E: N.1129
- Ligands: NAG.75
Ligand excluded by PLIPNAG.49: 3 residues within 4Å:- Chain B: N.57
- Chain D: N.57
- Ligands: NAG.19
Ligand excluded by PLIPNAG.50: 7 residues within 4Å:- Chain B: N.118, T.120, V.123
- Chain D: N.118, T.120, V.123
- Ligands: NAG.20
Ligand excluded by PLIPNAG.51: 5 residues within 4Å:- Chain B: N.159, N.160
- Chain D: N.159, N.160
- Ligands: NAG.21
Ligand excluded by PLIPNAG.52: 11 residues within 4Å:- Chain A: R.452, S.454, K.455, K.457
- Chain B: T.104, N.229, T.231
- Chain D: T.104, N.229, T.231
- Ligands: NAG.22
Ligand excluded by PLIPNAG.53: 6 residues within 4Å:- Chain A: K.553
- Chain B: E.276, N.277
- Chain D: E.276, N.277
- Ligands: NAG.23
Ligand excluded by PLIPNAG.54: 5 residues within 4Å:- Chain B: N.326, Q.575
- Chain D: N.326, Q.575
- Ligands: NAG.24
Ligand excluded by PLIPNAG.55: 7 residues within 4Å:- Chain B: H.334, N.338, F.366
- Chain D: H.334, N.338, F.366
- Ligands: NAG.25
Ligand excluded by PLIPNAG.56: 9 residues within 4Å:- Chain B: N.611, T.613, Q.639
- Chain C: I.829
- Chain D: N.611, T.613, Q.639
- Chain E: I.829
- Ligands: NAG.26
Ligand excluded by PLIPNAG.57: 3 residues within 4Å:- Chain B: N.652
- Chain D: N.652
- Ligands: NAG.27
Ligand excluded by PLIPNAG.58: 7 residues within 4Å:- Chain B: Y.702, S.703, N.704
- Chain D: Y.702, S.703, N.704
- Ligands: NAG.28
Ligand excluded by PLIPNAG.59: 7 residues within 4Å:- Chain B: E.1067, N.1069
- Chain C: Q.890
- Chain D: E.1067, N.1069
- Chain E: Q.890
- Ligands: NAG.29
Ligand excluded by PLIPNAG.60: 3 residues within 4Å:- Chain B: N.1129
- Chain D: N.1129
- Ligands: NAG.30
Ligand excluded by PLIPNAG.64: 3 residues within 4Å:- Chain C: N.57
- Chain E: N.57
- Ligands: NAG.34
Ligand excluded by PLIPNAG.65: 7 residues within 4Å:- Chain C: N.118, T.120, V.123
- Chain E: N.118, T.120, V.123
- Ligands: NAG.35
Ligand excluded by PLIPNAG.66: 5 residues within 4Å:- Chain C: N.159, N.160
- Chain E: N.159, N.160
- Ligands: NAG.36
Ligand excluded by PLIPNAG.67: 15 residues within 4Å:- Chain B: R.452, S.454, K.455, K.457
- Chain C: T.104, N.229, T.231
- Chain D: R.452, S.454, K.455, K.457
- Chain E: T.104, N.229, T.231
- Ligands: NAG.37
Ligand excluded by PLIPNAG.68: 7 residues within 4Å:- Chain B: K.553
- Chain C: E.276, N.277
- Chain D: K.553
- Chain E: E.276, N.277
- Ligands: NAG.38
Ligand excluded by PLIPNAG.69: 5 residues within 4Å:- Chain C: N.326, Q.575
- Chain E: N.326, Q.575
- Ligands: NAG.39
Ligand excluded by PLIPNAG.70: 7 residues within 4Å:- Chain C: H.334, N.338, F.366
- Chain E: H.334, N.338, F.366
- Ligands: NAG.40
Ligand excluded by PLIPNAG.71: 8 residues within 4Å:- Chain A: I.829
- Chain C: N.611, T.613, Q.639
- Chain E: N.611, T.613, Q.639
- Ligands: NAG.41
Ligand excluded by PLIPNAG.72: 3 residues within 4Å:- Chain C: N.652
- Chain E: N.652
- Ligands: NAG.42
Ligand excluded by PLIPNAG.73: 7 residues within 4Å:- Chain C: Y.702, S.703, N.704
- Chain E: Y.702, S.703, N.704
- Ligands: NAG.43
Ligand excluded by PLIPNAG.74: 6 residues within 4Å:- Chain A: Q.890
- Chain C: E.1067, N.1069
- Chain E: E.1067, N.1069
- Ligands: NAG.44
Ligand excluded by PLIPNAG.75: 3 residues within 4Å:- Chain C: N.1129
- Chain E: N.1129
- Ligands: NAG.45
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tsujino, S. et al., Virological characteristics of the SARS-CoV-2 Omicron EG.5.1 variant. Microbiol Immunol (2024)
- Release Date
- 2024-04-24
- Peptides
- Spike glycoprotein: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
A
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 60 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tsujino, S. et al., Virological characteristics of the SARS-CoV-2 Omicron EG.5.1 variant. Microbiol Immunol (2024)
- Release Date
- 2024-04-24
- Peptides
- Spike glycoprotein: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
A